Subrenal_capsule_assay_using_nude_mice_as_a_predictor_of_the_response_of_the_gastric_cancer_to_chemotherapy._Feasibility_of_utilizing_human_gastric_cancers_as_first_transplant_generation_xenografts_in_nude_mice_for_determining_tumor_sensitivity_to_chemotherapeutic_agents_was_demonstrated_by_applying_subrenal_capsule_(SRC)_assay._A_total_of_55_human_gastric_tumors_from_patients_were_tested_in_this_assay._Mitomycin-C_(MMC)_and_hexycarbamyl-5-FU_(HCFU,_5-FU_derivative)_were_selected_for_the_treatment_of_these_patients_after_surgery_and_also_for_this_assay_as_first_transplant._Evaluable_rate_of_MMC_in_this_assay_was_92.7%_and_that_of_HCFU_was_90.9%._Sensitivity_of_tumors_to_MMC_was_25%_and_to_HCFU_was_32%._Correlation_between_response_to_chemotherapy_of_human_tumors_in_patients_and_in_nude_mice_was_78.6%._These_results_indicate_that_this_assay_could_predict_effective_drugs_for_patients_with_gastric_cancer.